Hamas has demonstrated that it uses building materials for attack tunnels and underground lairs, not schools, homes, and hospitals
What happened when a bunch of kids took over America’s second-largest burger chain
Before they can be sent home, they need to be housed, fed, and given court dates
The average American spends more time per day on Facebook than on pet care
Cynk had no assets and no revenue. But it got a $6 billion valuation. Then it blew up
The check-in app is now a search app, and its logo has changed accordingly
The company saw 11 percent growth in earned premiums, and it's now the No. 2 auto insurer behind State Farm
Judy Olian offers nine ideas to boost the number of women and other minorities on b-school faculty
For chief executive officers, correlation between pay and stock performance is pretty random, as this chart illustrates
Founders: Cam Garner, Elaine Phillips, Malcolm Hill, and Adam Simpson
VC Investment over the last four quarters: $22.5 million
Founded in 2008, this nine-employee drug company develops products for the treatment of allergic inflammation of the gastrointestinal tract. "We identified a market that we believe has a true unmet medical need—in this particular instance there is no product approved by the FDA for the treatment of eosinophilic esophagitis," says a Meritage spokesperson in an e-mail. In the midst of the recession, its founders say that it is particularly important to stay focused on execution.
Key to startup success: "If we are able to successfully develop safe and effective products to meet the unmet medical needs of patients and their caregivers, we believe that capital will continue to be available."